A practical reference on half-life: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-02-08. Anything still debated is marked as such rather than presented as settled.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
The compound binds the GLP-1 receptor on pancreatic beta cells and other tissues, activating a G-protein signaling cascade that raises intracellular cyclic AMP. This action increases glucose-dependent insulin secretion when blood glucose is elevated, while binding also slows gastric emptying and reduces glucagon release. In the central nervous system, receptor activation in the hypothalamus and brainstem contributes to reduced appetite. The fatty acid chain binds albumin, which protects the peptide from renal filtration and enzymatic degradation. This albumin binding is central to its extended circulation time.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | Not a small molecule |
| Backbone substitutions | Non-natural residue at position 8, arginine at position 34 | Slows enzymatic cleavage |
| Side chain | C18 fatty diacid with PEG linker | Enables albumin binding |
| Approximate molecular mass | 4114 Da | Varies slightly with salt form |
| Reported half-life | About one week | Longer than native GLP-1 by orders of magnitude |
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。
市售注射用制剂通常要求在二至八摄氏度冷藏保存，并避免光照与冻结。部分多剂量笔在首次使用后允许在不超过三十摄氏度的环境中存放有限周数，具体期限由辅料与防腐剂体系决定。反复冻融会促进肽链聚集并改变可见颗粒计数，因此应予避免。冻干粉末在干燥、避光、低温条件下更为稳定。溶液配制后宜使用低吸附容器，以减少肽类在塑料或玻璃表面的损失。
Quality control for peptide material focuses on identity, purity, content and the profile of impurities. Common degradants include deamidated and oxidised forms, plus aggregates formed during storage or handling. Forced degradation studies under heat, light, acid and peroxide help define which conditions accelerate change and which analytical methods detect it. Limits for individual impurities are set by pharmacopoeial monographs or manufacturer specifications. How much a given impurity affects biological activity is often uncertain, and conclusions may depend on the assay used.
Solid peptide material is generally kept at reduced temperature to limit degradation. Short-term storage at 2 to 8 degrees Celsius is common, while longer archival storage at minus 20 degrees Celsius or below is typical for lyophilised powder. Vials should remain sealed and protected from light, because ultraviolet exposure can oxidise susceptible residues. Repeated freeze-thaw cycles are avoided, as they promote aggregation and loss of soluble material. Solutions are less stable than solids and are usually prepared close to the time of use.
Lyophilised semaglutide is generally held at -20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept at 2-8 °C and used within a defined window because degradation accumulates over time. Repeated freeze-thaw cycles are discouraged, since each cycle can promote aggregation and reduce monomeric content. Room-temperature stability of the solid has been examined in some studies but remains incompletely characterised for long durations, so cold storage is the conservative default for research material.
Degradation proceeds along several parallel routes. Deamidation of asparagine and glutamine residues generates charged variants that shift retention time in chromatographic analysis. Oxidation targets methionine and can be accelerated by trace metals or dissolved oxygen. Non-covalent aggregation produces dimers, oligomers, and larger species that are difficult to reverse. Isomerisation at aspartate residues is slower but measurable under thermal stress. The distribution among these pathways depends on pH, buffer composition, ionic strength, and the presence of excipients such as sugars or surfactants.
== Factors that affect pKa values == Pauling's second rule is that the value of the first pKa for acids of the formula XOm(OH)n depends primarily on the number of oxo groups m, and is approximately independent of the number of hydroxy groups n, and also of the central atom X. Approximate values of pKa are 8 for m = 0, 2 for m = 1, −3 for m = 2 and < −10 for m = 3. Alternatively, various numerical formulas have been proposed including pKa = 8 − 5m (known as Bell's rule), pKa = 7 − 5m, or pKa = 9 − 7m. The dependence on m correlates with the oxidation state of the central atom, X: the higher the oxidation state the stronger the oxyacid. For example, pKa for HClO is 7.2, for HClO2 is 2.0, for HClO3 is −1 and HClO4 is a strong acid (pKa ≪ 0). The increased acidity on adding an oxo group is due to stabilization of the conjugate base by delocalization of its negative charge over an additional oxygen atom. This rule can help assign molecular structure: for example, phosphorous acid, having molecular formula H3PO3, has a pKa near 2, which suggested that the structure is HPO(OH)2, as later confirmed by NMR spectroscopy, and not P(OH)3, which would be expected to have a pKa near 8.
=== Regionalized menus === KFC adapts its menu internationally to suit regional tastes and there are over 300 KFC menu items worldwide. Some locations, such as the UK and the US, sell grilled chicken. In predominantly Islamic countries, the chicken served is halal. In Asia, there is a preference for spicy foods, such as the Zinger chicken burger. In many international markets, the seasoning used for the core chicken pieces product is available as a hot and spicy version as an alternative to the classic KFC recipe. The hot and spicy coating, as well as having a spicier flavour, also has a crispy consistency. In Bangladesh, India, Nepal and Sri Lanka, a grilled chicken known as "Smoky Red" is available. KFC locations in Taiwan, Hong Kong, Macau and Vietnam offer a roasted option known as Flava Crava. KFC's menu in China includes, among other items incorporating Chinese food items, rice bowls, noodle dishes, and chicken prepared in the style of Peking duck. Some locations in the US sell fried chicken livers and gizzards. A small number of US outlets offer an all-you-can-eat buffet option with a limited menu. Value menu items are sold under the "Streetwise" name in locations such as Canada, Nigeria, South Africa and Mauritius. Side dishes often include French fries, coleslaw, barbecue baked beans, corn on the cob, mashed potato, bread rolls and American biscuits. Salads include the bean salad, the Caesar salad and the garden salad. In a number of territories, KFC sells onion rings.
== Description == One of the beautiful, intelligent and smart fish,"The King betta" generally grows to about 5–6 cm (2–2 1/2 in). Its pigments are generally vibrant beige to a white. As with most bettas, King betta females are smaller (even the fins) and less colorful than the males. The king betta can be happy or even aggressive based on the environment and can be trained easily (rather than the wild bettas') and they remember their owners for longer time period. The life span of the King betta is short, generally 2–3 years, rarely reaching four. The King betta is (as are all other bettas) members of the gourami family (Osphronemidae) and prefers a temperature of 78–82 °F.
=== Example for carbon-14 === Carbon-14 has a half-life of 5700(30) years and a decay rate of 14 disintegrations per minute (dpm) per gram of natural carbon. If an artifact is found to have radioactivity of 4 dpm per gram of its present C, we can find the approximate age of the object using the above equation:
Sources: en.wikipedia.org
=== E1 subunit === E1 uses thiamine pyrophosphate (TPP) as a catalytic cofactor. E1 catalyzes both the decarboxylation of the α-ketoacid and the subsequent reductive acylation of the lipoyl moiety (another catalytic cofactor) that is covalently bound to E2.
== Uses == Since 1990, erythritol has had a history of safe use as a sweetener and flavor-enhancer in food and beverage products and is approved for use by government regulatory agencies in more than 60 countries. Beverage categories for its use are coffee and tea, liquid dietary supplements, juice blends, soft drinks, and flavored water product variations, with foods including confections, biscuits and cookies, tabletop sweeteners, and sugar-free chewing gum. The mild sweetness of erythritol allows for a volume-for-volume replacement of sugar, whereas sweeter sugar substitutes need fillers that result in a noticeably different texture in baked products. Erythritol is also used as a humectant.
==== Agriculture ==== When a soil becomes too dry, plant transpiration drops because the water is increasingly bound to the soil particles by suction. Below the wilting point plants are no longer able to extract water. At this point they wilt and cease transpiring altogether. Conditions where soil is too dry to maintain reliable plant growth is referred to as agricultural drought, and is a particular focus of irrigation management. Such conditions are common in arid and semi-arid environments. Some agriculture professionals are beginning to use environmental measurements such as soil moisture to schedule irrigation. This method is referred to as smart irrigation or soil cultivation.
fasting capillary blood glucose levels <5.5 mmol/L 1 hour postprandial capillary blood glucose levels <8.0 mmol/L 2-hour postprandial blood glucose levels <6.7 mmol/L Regular blood samples can be used to determine HbA1c levels, which give an idea of glucose control over a longer period. Research suggests a possible benefit of breastfeeding to reduce the risk of diabetes and related risks for both mother and child.
After a strong pre-season, Melksham had strong form during the 2012 NAB Cup, which led to former Essendon player and The Age journalist, Matthew Lloyd naming Melksham as one of the players who would have a breakout season. After the club had an outstanding start to the season where the team won eight out of nine matches, with the only loss being one point to Collingwood in the Anzac Day clash; hype surrounding the club was immense with 1987 premiership coach, Robert Walls denoting the club could win a premiership, indicating the improvement of the players, especially Melksham, was one of the reasons for a potential flag. Garry Lyon also noted the improvement of Melksham as one of the reasons for Essendon's strong start to the season, along with The Age journalist, Martin Flanagan, praising Melksham and his contribution to the club's fortunes. After round nine, the club lost ten of the final thirteen matches, including the final seven to finish outside of the top eight; the decline in the teams' performance saw Melksham's form dip as well, with The Age journalist, Rohan Connolly stating Melksham's development had "stalled". Despite being one of two players to play every match during the season, he failed to finish inside the top ten in the club best and fairest.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.
Albumin binding keeps a large fraction of the compound in a slowly released reservoir within the bloodstream. Plasma levels decline gradually rather than falling sharply after each administration. That profile supports dosing intervals measured in days instead of hours.
The active peptide sequence is the same in both formats. The oral version adds an absorption enhancer that is not present in the injected solution. Differences in excipients and formulation affect uptake rather than the identity of the active molecule.
It is a synthetic analog of GLP-1 produced through medicinal chemistry to resist enzymatic degradation. The design goal was longer circulation than the native hormone.